ArticleDiabetology & metabolic syndrome2018

Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study.

Yi-Hsuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.